Business profile & competitive position
CF Industries Holdings, Inc. operates in the Basic Materials sector, specifically the Agricultural Inputs industry. Its core business is producing anhydrous ammonia through the Haber-Bosch process and then either selling that ammonia directly or upgrading it into nitrogen products such as granular urea, UAN, ammonium nitrate, and diesel exhaust fluid. The company serves agricultural, industrial, explosives, and emissions-control customers from manufacturing facilities in the United States, Canada, and the United Kingdom, backed by a North American distribution and logistics network.
The margin and return figures speak directly to competitive positioning. CF's net margin is 27.1% and return on equity is 40.4%, both high for a commodity-linked manufacturer. In nitrogen fertilizer—where pricing is cyclical and input costs are a decisive factor—returns like that normally come from scale advantages, feedstock access, and operating leverage. That fits with the 10-K disclosure that the Donaldsonville, Louisiana facility is the world's largest and most flexible ammonia production complex, and with natural gas accounting for roughly 34% of total production costs in 2025 and about 350 million MMBtus consumed across the network. A beta of 0.40, meanwhile, suggests the stock trades with materially less volatility than the overall market even though it sits in a cyclical industry.
Financial posture
At a $20.5 billion market capitalization and a 9.9 P/E multiple, CF is priced like a cyclical cash generator rather than a growth stock. The 27.1% net margin and 40.4% ROE reinforce that profile: the business is currently generating strong returns on its equity base while carrying a low-double-digit earnings multiple. That combination often reflects either a market pricing in cyclical downside or a company returning large amounts of cash and being valued on trough or normalized earnings.
The balance between valuation and profitability is important. A P/E under 10 with ROE above 40% is unusual outside of deeply cyclical or commodity-exposed businesses, and it implies that investors are treating current earnings as potentially unsustainable at this level. The 0.40 beta adds another wrinkle: despite being tied to agriculture and natural gas, the equity has historically moved with less amplitude than the broader market, which can affect both hedging and portfolio-construction considerations.
Strategic priorities & outlook
CF's most recent 10-K frames its strategy around advantaged production, operational excellence, disciplined capital stewardship, and a long-term pivot toward clean energy. Specifically, the company plans to decarbonize its existing ammonia production network through carbon capture and sequestration projects, with Yazoo City CCS expected to commence in 2028. It is also building the Blue Point greenfield low-carbon ammonia facility with JERA and Mitsui, with production targeted for 2029.
Beyond carbon capture, CF is pursuing demand for low-carbon ammonia and upgraded products for traditional fertilizer uses and newer applications such as power generation, marine shipping, and steel production. Near-term operations, however, include a notable headwind: production at Yazoo City is temporarily idled after a November 2025 incident and is not expected to resume until the fourth quarter of 2026 at the earliest. That means low-carbon project timelines need to be weighed against lost near-term output at one facility.
Macro & geopolitical exposure
As an Agricultural Inputs company, CF is exposed to the cycle in crop prices and farm cash incomes, which drive fertilizer application rates. Corn and soybean economics, planting acreage, and weather conditions in North America all flow through to demand for nitrogen fertilizers. At the same time, natural gas is the dominant feedstock, so CF's margins are sensitive to North American gas prices and, to a lesser extent, international gas benchmarks.
Trade policy also matters for fertilizer producers. Tariffs, import duties on foreign nitrogen, or export restrictions from major producing regions can materially move regional pricing. CF's U.S., Canadian, and U.K. footprint adds currency exposure and cross-border regulatory complexity, especially as carbon-transition rules in Europe evolve. Broader energy-transition policy and carbon-credit frameworks can either accelerate or delay the economics of low-carbon ammonia projects, which are central to the 10-K strategic plan.
Recent developments
Recent news flow has highlighted both the stock's run and the debate about its valuation. On September 4, 2026, Zacks published "CF (CF) Up 18.1% Since Last Earnings Report: Can It Continue?", reflecting the rally since the August 5, 2026 report. The same day, 247wallst.com covered broader commodity commentary with "Jim Cramer Saw Copper Reaching $100, Yet One Trader Bought the Drop," which included CF in the fertilizer/commodity trade discussion. Two days earlier, on September 2, 2026, Seeking Alpha ran "CF Industries: Still Misunderstood, Still Undervalued," and Zacks on September 1, 2026, noted "CF Shares Up 15% in 3 Months: Here's What's Driving the Upside." The current price of $133.35 sits above the 50-day EMA of $123.04, with an RSI of 60.6, suggesting the recent move has been strong but not yet extreme on a momentum basis.
Earnings behavior & post-earnings drift
CF has beaten Wall Street EPS estimates in 6 of the last 8 reported quarters, a 75% beat rate, with an average earnings surprise of 14.5%. In the five trading days after each release over that period, the stock has averaged a 1.9% gain, with the direction officially classified as "up." That sounds like a clean pattern—beats plus positive drift—but the quarter-by-quarter history is more complicated.
The most recent report, on August 5, 2026, showed a 16% miss: actual EPS was $4.73 against an estimate of $5.63. The next-day move was essentially flat at +0.02%, and the stock rose 2.83% over the following five sessions. Compare that to the May 6, 2026 quarter, when CF beat by 51.7% ($3.99 vs. $2.63) yet fell 0.9% the next day, though it did rise 4.79% over the next five sessions. The February 18, 2026 beat of 23% delivered a 3.8% next-day pop but only a 0.33% five-day drift. The November 5, 2025 quarter, a 1.4% beat, dropped 4.23% the next day and eked out a -0.35% five-day drift.
The takeaway is that beats have not reliably produced immediate or sustained rallies, and the August miss actually preceded the stock's recent 18.1% run. That disconnect is a useful reminder that the market's real expectation for CF often includes forward-looking nitrogen pricing, gas-cost assumptions, and capital-return commentary, not just the reported EPS number. The next data point arrives after the close on November 4, 2026, when the consensus EPS estimate is $3.02.
Frequently Asked Questions
What drives CF Industries' cost advantage?
Natural gas is the principal raw material, accounting for approximately 34% of total 2025 production costs and roughly 350 million MMBtus of facility consumption. Scale at the Donaldsonville complex and access to low-cost North American gas help support the 27.1% net margin and 40.4% ROE.
Why didn't CF's latest earnings miss sink the stock?
On August 5, 2026, CF reported EPS of $4.73 versus an estimate of $5.63, a 16% miss, but the stock rose 0.02% the next day and 2.83% over the following five sessions. That suggests investors had already priced in weak results or were more focused on forward commodity pricing, gas-cost expectations, and capital-return outlook.
When is CF's next earnings report and what is expected?
CF is scheduled to report after the market close on November 4, 2026, with a consensus EPS estimate of $3.02. Over the previous eight quarters the company beat estimates 75% of the time, with an average surprise of 14.5%.
For a deeper dive, review the full institutional verdict on CF, including aggregated analyst ratings, consensus target context, and model assumptions, to see how professionals weight the nitrogen cycle, carbon-transition projects, and valuation against the operational facts above.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-05 | $4.73 | $5.63 | -16% | +0.02% | +2.83% |
| 2026-05-06 | $3.99 | $2.63 | +51.7% | -0.9% | +4.79% |
| 2026-02-18 | $2.99 | $2.43 | +23% | +3.8% | +0.33% |
| 2025-11-05 | $2.19 | $2.16 | +1.4% | -4.23% | -0.35% |
| 2025-08-06 | $2.37 | $2.5 | -5.2% | - | - |
| 2025-05-07 | $1.85 | $1.48 | +25% | - | - |
Previous CF editions
Get the institutional verdict on CF
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CF verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.